A randomized trial of daclatasvir in combination with asunaprevir and beclabuvir in patients with chronic hepatitis C virus genotype 4 infection

Saved in:
Bibliographic Details
Published in:Journal of hepatology 2015-05, Vol.62 (5), p.1204-1206
Main Authors: Hassanein, Tarek, Sims, Karen D, Bennett, Michael, Gitlin, Norman, Lawitz, Eric, Nguyen, Tuan, Webster, Lynn, Younossi, Zobair, Schwartz, Howard, Thuluvath, Paul J, Zhou, Helen, Rege, Bhaskar, McPhee, Fiona, Zhou, Nannan, Wind-Rotolo, Megan, Chung, Ellen, Griffies, Amber, Grasela, Dennis M, Gardiner, David F
Format: Article
Language:English
Subjects:
Adult
Antiviral Agents - administration & dosage
Antiviral Agents - adverse effects
Benzazepines - administration & dosage
Benzazepines - adverse effects
Drug Monitoring
Drug Resistance, Viral
Enzyme Inhibitors - administration & dosage
Enzyme Inhibitors - adverse effects
Female
Gastroenterology and Hepatology
Hepacivirus - drug effects
Hepacivirus - genetics
Hepatitis C, Chronic - drug therapy
Hepatitis C, Chronic - virology
Humans
Imidazoles - administration & dosage
Imidazoles - adverse effects
Indoles - administration & dosage
Indoles - adverse effects
Isoquinolines - administration & dosage
Isoquinolines - adverse effects
Male
Middle Aged
Sulfonamides - administration & dosage
Sulfonamides - adverse effects
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0168-8278
1600-0641
DOI:10.1016/j.jhep.2014.12.025